Clinical trial
Lupus Atherosclerosis Prevention Study
NCT00120887 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00120887 |
|---|---|
| Title | Lupus Atherosclerosis Prevention Study |
| Official title | Lupus Atherosclerosis Prevention Study |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | Lupus Research Alliance |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Systemic Lupus Erythematosus |
| Intervention type | Drug |
| Interventions | Atorvastatin |
| Enrollment | 200 |
| Start date | Apr 1, 2002 |
| Completion | Dec 1, 2005 |
| First posted | Jul 19, 2005 |
| Last update posted | Apr 5, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: